Legal Representation
Attorney
Norm J. Rich
USPTO Deadlines
Next Deadline
28 days remaining
Published for Opposition
Due Date
January 15, 2026
Extension Available
Until February 15, 2026
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 16, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 16, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 11, 2025 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Dec 10, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 26, 2025 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Nov 25, 2025 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Nov 25, 2025 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Nov 15, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 18, 2025 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Oct 14, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 14, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 14, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 27, 2025 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Sep 27, 2025 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Aug 16, 2025 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Aug 15, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 2, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 9, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Apr 9, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 8, 2025 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED | Loading... |
| Apr 3, 2025 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; tumor suppressing agents; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; immunomodulators and immunosuppressive agents being pharmaceutical preparations for the treatment of immune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for treating hematological disorders; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines being anti-emetic preparations; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations; chemical reagents for medical purposes in the field of oncology
Classification
International Classes
005